{"id":422677,"title":"ARCHIVED Updated requirements for COVID-19 drug authorizations: Notice - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-16","captureTimestamp":"2026-01-16T20:09:23.942000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/updated-requirements-drug-authorization-notice.html?wbdisable=false","snippet":"ARCHIVED Updated requirements for COVID-19 drug authorizations: Notice COVID-19 drugs that were authorized in Canada under the Interim order respecting the importation, sale and advertising of drugs for use in relation to COVID-19 (ISAD IO) were able to transition and file a new…","rawSnapshotUrl":"/api/snapshots/raw/422677","browseUrl":"https://replay.healtharchive.ca/job-6/20260116200923/https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/updated-requirements-drug-authorization-notice.html?wbdisable=false#ha_snapshot=422677","mimeType":"text/html","statusCode":200}